CLINICAL_TRIALS
trial_result
· 2017-05-10
Clinical Trial Update: Tailoring of Vaccine-Focused Messages: Disease Salience [NA]
Summary
Emory University conducted a study evaluating tailored vaccine-focused messages for disease salience related to Human papillomavirus infection. The trial status…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Emory University | Conditions: Human Papillomavirus | NA | Status: COMPLETED